Full history for every metric is available with a Kvantra account

Walgreens Boots Alliance, Inc. (WBA)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 120 | 122 | 133 | 133 | 139 | 148 | 155 |
| Operating profit | $bn | -14 | -3 | |||||
| Net profit | $bn | 4 | 0 | 3 | 4 | -3 | -9 | -6 |
| EPS reported | $ | -10.01 | -7.29 | |||||
| Operating cashflow per share | $ | 1.18 | 1.18 | |||||
| Capex per share | $ | 1.60 | 1.60 | |||||
| FCF per share | $ | -0.42 | -0.42 | |||||
| Free cash flow | $bn | -0 | 1 | |||||
| Net debt | $bn | 6 | 7 | |||||
| Book value equity | $bn | 10 | 7 | |||||
| Book value per share | $ | 12.10 | 8.31 | |||||
| Number of shares | m | 863.1 | 864.9 | |||||
| DPS (TTM paid) | $ | 1.00 | 0.50 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.76 | 1.44 | |||||
| P/S LTM | x | 0.05 | 0.07 | |||||
| P/FCF LTM | x | -21.99 | 17.88 | |||||
| EV/EBITDA LTM | x | -3.59 | -5.79 | |||||
| EV/Sales LTM | x | 0.27 | 0.11 | |||||
| Earnings Yield LTM | % | -108.17% | -83.52% | |||||
| FCF Yield | % | -4.55% | 5.59% | |||||
| Quality | ||||||||
| ROE | % | -82.68% | -56.69% | |||||
| ROIC | % | -24.28% | -24.28% | |||||
| Operating margin | % | -9.53% | -9.53% | |||||
| Gross margin | % | 17.96% | 17.96% | |||||
| FCF/Sales | % | -0.25% | -0.25% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +6.17% | +6.22% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 15.78% | 4.17% | |||||
| Dividend Growth | % | -47.92% | - | |||||
| Payout Ratio | % | -14.59% | -10.29% | |||||
| FCF/Debt | x | -0.01 | 0.02 | |||||
| Net Debt/EBITDA | x | -2.88 | -2.88 | |||||
| EBIT/Net interest | x | -29.20 | -29.20 | |||||
| Net debt/market cap | % | 80.66% | 63.03% | |||||
| Net debt/Equity | x | 0.62 | 0.91 | |||||
| Gross debt/equity | x | 3.23 | 4.04 | |||||
Company overview
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Walgreens Boots Alliance, Inc. (WBA)
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free